A symposium: Rosuvastatin-An Efficacy Assessment Based on Pooled Trial DataSTEIN, Evan A.The American journal of cardiology. 2003, Vol 91, Num 5A, issn 0002-9149, 31 p.Conference Proceedings

Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome. DiscussionsBALLANTYNE, Christie M; STEIN, Evan A; PAOLETTI, Rodolfo et al.The American journal of cardiology. 2003, Vol 91, Num 5A, pp 25C-28C, issn 0002-9149Conference Paper

Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin. DiscussionsRADER, Daniel J; DAVIDSON, Michael H; CAPLAN, Richard J et al.The American journal of cardiology. 2003, Vol 91, Num 5A, pp 20C-24C, issn 0002-9149Conference Paper

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. DiscussionsBLASETTO, James W; STEIN, Evan A; BROWN, W. Virgil et al.The American journal of cardiology. 2003, Vol 91, Num 5A, pp 3C-10C, issn 0002-9149Conference Paper

Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. DiscussionsSHEPHERD, James; HUNNINGHAKE, Donald B; BARTER, Philip et al.The American journal of cardiology. 2003, Vol 91, Num 5A, pp 11C-19C, issn 0002-9149Conference Paper